Pharmafile Logo
Pharmafocus logo
Advanced Search

Teva

Showing 15 posts of 234 posts found.

Teva image

Teva to axe 5,000 jobs in savings drive

October 11, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Copaxone, FDA, Teva, cuts

The world’s largest generic drugmaker Teva will cut around 5,000 jobs from its global workforce as it looks to speed-up …

News
teva_copy

Teva in Cancer Research UK tie-up

September 20, 2013
Medical Communications, Research and Development, Sales and Marketing CRUK, Cancer, R&D, Teva

News
bowel_cancer_screening

FDA approves first generic Xeloda

September 17, 2013
Sales and Marketing FDA, Roche, Teva, Xeolda, breast cancer, colorectal cancer

News
Lonza image

Teva and Lonza abandon biosimilars joint venture

July 26, 2013
Manufacturing and Production, Research and Development CMO, Levin, Lonza, Teva, biosimilars

Escalating costs have led Teva and contract manufacturing organisation (CMO) Lonza to abandon a joint venture set up in 2009 …

News
Teva image

No evidence of fault at Teva plant linked to drug switch death

June 14, 2013
Manufacturing and Production Teva, death

France’s medicines regulator has concluded that a plant operated in the country by generic drugmaker Teva was not at fault …

News
Teva image

Pfizer wins $2.15 billion patent case

June 13, 2013
Sales and Marketing Pfizer, Takeda, Teva, protonix

Pfizer and Takeda are to split $2.15 billion in damages from two generics manufacturers as a settlement for lost sales, …

News
furosemide image

French regulator probes Teva plant after patient death

June 12, 2013
Manufacturing and Production Teva, furosemide, zopiclone

France’s medicines regulator has started an investigation into a manufacturing facility operated by generic firm Teva in the wake of …

News
Teva image

Fatality as blast rocks Teva manufacturing plant

May 31, 2013
Manufacturing and Production Teva

One man died and more than 30 other people were injured after an explosion hit a manufacturing facility operated by …

News
Teva image

Teva says US facility will close in cost-cutting drive

May 3, 2013
Manufacturing and Production Teva, closure, cuts

Teva has said it will shut down a manufacturing and R&D facility in Pennsylvania by 2017, with the loss of …

News
teva image

Teva plans sale of troubled Irvine plant

February 11, 2013
Manufacturing and Production FDA, Teva

Teva has decided to sell off an injectable pharmaceutical production plant in Irvine, California, that was shut down temporarily for …

News
screen_shot_2013-02-11_at_11

Teva appoints Arie Belldegrun to Board of directors

February 11, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Arie Belldegrun, Teva

Teva Pharmaceuticals has announced that Dr Arie Belldegrun has been appointed by the directors of Teva to fill a vacancy …

Appointment
teva image

Teva revamp will see manufacturing shake-up

December 17, 2012
Manufacturing and Production Levin, Teva, manufacturing

Teva’s recent announcement of a major restructuring of its business to cut costs and maintain profitability includes a revamp of …

News
Hospira image

Hospira on track to return propofol to market

November 13, 2012
Manufacturing and Production Ball, Hospira, Teva

Shortages of the short-acting anaesthetic propofol in the US could be helped by the return to market of a generic …

News
speakerwilliamsmarth

Leadership changes at Teva

November 8, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Levin, Teva

Teva Pharmaceutical has announced some management changes to its executive leadership team. Allan Oberman, senior vice president of North America …

Appointment
teva image

Teva’s CML drug approved

October 29, 2012
Research and Development, Sales and Marketing FDA, Synribo, Teva

Teva’s new treatment for chronic myeloid leukemia Synribo has been approved by the FDA. Synribo (omacetaxine mepesuccinate) is an injectable …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026